All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy

Yahoo FinanceDec 19 01:00

Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress

AccesswireDec 11 01:50

Why Vision Marine Technologies Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket

BenzingaDec 2 19:29

Vivos Therapeutics Price Target Maintained With a $6.60/Share by Ascendiant Capital

Dow JonesNov 20 17:54 · Ratings

Vivos Therapeutics Is Maintained at Buy by Alliance Global Partners

Dow JonesNov 20 01:08 · Ratings

Vivos Therapeutics Analyst Ratings

BenzingaNov 20 00:57 · Ratings